Immune mechanisms in cerebral ischemic tolerance

Frontiers in Neuroscience

Volumn , Issue 8 MAR, 2014, Pages

  Garcia Bonilla, Lidia ^a   Benakis, Corinne ^a   Moore, Jamie ^a   Iadecola, Costantino ^a   Anrather, Josef ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Epigenetics; Inflammation; Ischemic tolerance; MicroRNAs; Preconditioning; Stroke; TLR; TNF

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 6; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ANESTHESIA; BIOLOGICAL FUNCTIONS; BRAIN DEPTH STIMULATION; BRAIN HYPOXIA; BRAIN ISCHEMIA; CEREBRAL ISCHEMIC TOLERANCE; CHROMATIN STRUCTURE; DEPOLARIZATION; DNA MODIFICATION; EXERCISE; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; HYPEROXIA; HYPERTHERMIA; HYPOTHERMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; ISCHEMIC PRECONDITIONING; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; SEIZURE; SPREADING CORTICAL DEPRESSION; SUMOYLATION;

EID: 84898022439     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00044     Document Type: Review

References (208)

1. Abe, T., Shimamura, M., Jackman, K., Kurinami, H., Anrather, J., Zhou, P., et al. (2010). Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke 41, 898-904. doi: 10.1161/STROKEAHA.109.572552.
2. Ahmed, S. H., He, Y. Y., Nassief, A., Xu, J., Xu, X. M., Hsu, C. Y., et al. (2000). Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke 31, 193-199. doi: 10.1161/01.STR.31.1.193.
3. Akira, S. (2009). Pathogen recognition by innate immunity and its signaling. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 85, 143-156. doi: 10.2183/pjab.85.143.
4. Allan, S. M., Tyrrell, P. J., and Rothwell, N. J. (2005). Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640. doi: 10.1038/nri1664.
5. Ameri, A. (1999). The effects of cannabinoids on the brain. Prog. Neurobiol. 58, 315-348. doi: 10.1016/S0301-0082(98)00087-2.
6. Anderson, K. V., Bokla, L., and Nüsslein-Volhard, C. (1985). Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product. Cell 42, 791-798. doi: 10.1016/0092-8674(85)90275-2.
7. Aneja, R., Odoms, K., Dunsmore, K., Shanley, T. P., and Wong, H. R. (2006). Extracellular heat shock protein-70 induces endotoxin tolerance in THP-1 cells. J. Immunol. 177, 7184-7192.
8. Anrather, J., and Hallenbeck, J. M. (2013). Biological networks in ischemic tolerance-rethinking the approach to clinical conditioning. Transl. Stroke Res. 4, 114-129. doi: 10.1007/s12975-012-0244-z.
9. Baeuerle, P. A., and Henkel, T. (1994). Function and activation of NF-kappaB in the immune system. Annu. Rev. Immunol. 12, 141-179. doi: 10.1146/annurev.iy.12.040194.001041.
10. Baldwin, A. S. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683. doi: 10.1146/annurev.immunol.14.1.649.
11. Banks, W. A. (2005). Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 11, 973-984. doi: 10.2174/1381612053381684.
12. Barone, F. C., White, R. F., Spera, P. A., Ellison, J., Currie, R. W., Wang, X., et al. (1998). Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29, 1937-1950. discussion: 1950-1951.
13. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233. doi: 10.1016/j.cell.2009.01.002.
14. Bianchi, M. E. (2007). DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukocyte Biol. 81, 1-5. doi: 10.1189/jlb.0306164.
15. Bigdeli, M. R., and Khoshbaten, A. (2008). In vivo preconditioning with normobaric hyperoxia induces ischemic tolerance partly by triggering tumor necrosis factor-alpha converting enzyme/tumor necrosis factor-alpha/nuclear factor-kappaB. Neuroscience 153, 671-678. doi: 10.1016/j.neuroscience.2008.02.064.
16. Blondeau, N., Widmann, C., Lazdunski, M., and Heurteaux, C. (2001). Activation of the nuclear factor-kappaB is a key event in brain tolerance. J. Neurosci. 21, 4668-4677.
17. Brea, D., Blanco, M., Ramos-Cabrer, P., Moldes, O., Arias, S., Pérez-Mato, M., et al. (2011). Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J. Cereb. Blood Flow Metab. 31, 1424-1431. doi: 10.1038/jcbfm.2010.231.
18. Breder, C. D., Hazuka, C., Ghayur, T., Klug, C., Huginin, M., Yasuda, K., et al. (1994). Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. Proc. Natl. Acad. Sci. U.S.A. 91, 11393-11397. doi: 10.1073/pnas.91.24.11393.
19. Cao, C.-X., Yang, Q.-W., Lv, F.-L., Cui, J., Fu, H.-B., and Wang, J.-Z. (2007). Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem. Biophys. Res. Commun. 353, 509-514. doi: 10.1016/j.bbrc.2006.12.057.
20. Cárdenas, A., Moro, M. A., Leza, J. C., O'Shea, E., Dávalos, A., Castillo, J., et al. (2002). Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. J. Cereb. Blood Flow Metab. 22, 1297-1302. doi: 10.1097/00004647-200211000-00002.
21. Ceulemans, A.-G. A., Zgavc, T. T., Kooijman, R. R., Hachimi-Idrissi, S. S., Sarre, S. S., and Michotte, Y. Y. (2010). The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J. Neuroinflammation 7, 74-74. doi: 10.1186/1742-2094-7-74.
22. Chan, P. H. (2001). Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21, 2-14. doi: 10.1097/00004647-200101000-00002.
23. Charo, I. F., and Ransohoff, R. M. (2006). The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621. doi: 10.1056/NEJMra052723.
24. Chen, G. Y., and Nuñez, G. (2010). Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 10, 826-837. doi: 10.1038/nri2873.
25. Chen, H., Song, Y. S., and Chan, P. H. (2009). Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow Metab. 29, 1262-1272. doi: 10.1038/jcbfm.2009.47.
26. Cheng, O., Ostrowski, R. P., Wu, B., Liu, W., Chen, C., and Zhang, J. H. (2011). Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia. Stroke 42, 484-490. doi: 10.1161/STROKEAHA.110.604421.
27. Cho, S., Park, E.-M., Zhou, P., Frys, K., Ross, M. E., and Iadecola, C. (2005). Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J. Cereb. Blood Flow Metab. 25, 493-501. doi: 10.1038/sj.jcbfm.9600058.
28. Clarkson, A. N. (2007). Anesthetic-mediated protection/preconditioning during cerebral ischemia. Life Sci. 80, 1157-1175. doi: 10.1016/j.lfs.2006.12.022.
29. Clemens, J. A., Stephenson, D. T., Yin, T., Smalstig, E. B., Panetta, J. A., Little, S. P., et al. (1998). Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-B in rats editorial comment. Stroke 29, 677-682. doi: 10.1161/01.STR.29.3.677.
30. Curry, A., Guo, M., Patel, R., Liebelt, B., Sprague, S., Lai, Q., et al. (2010). Exercise pre-conditioning reduces brain inflammation in stroke via tumor necrosis factor-a, extracellular signal-regulated kinase 1/2 and matrix metalloproteinase-9 activity. Neurol. Res. 32, 756-762. doi: 10.1179/174313209X459101.
31. Dawn, B., Xuan, Y.-T., Guo, Y., Rezazadeh, A., Stein, A. B., Hunt, G., et al. (2004). IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc. Res. 64, 61-71. doi: 10.1016/j.cardiores.2004.05.011.
32. Dharap, A., Bowen, K., Place, R., Li, L.-C., and Vemuganti, R. (2009). Transient focal ischemia induces extensive temporal changes in rat cerebral MicroRNAome. J. Cereb. Blood Flow Metab. 29, 675-687. doi: 10.1038/jcbfm.2008.157.
33. Dharap, A., and Vemuganti, R. (2010). Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. J. Neurochem. 113, 1685-1691. doi: 10.1111/j.1471-4159.2010.06735.x.
34. Di Marzo, V., Melck, D., Bisogno, T., and De Petrocellis, L. (1998). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521-528. doi: 10.1016/S0166-2236(98)01283-1.
35. Ding, Y.-H., Young, C. N., Luan, X., Li, J., Rafols, J. A., Clark, J. C., et al. (2005). Exercise preconditioning ameliorates inflammatory injury in ischemic rats during reperfusion. Acta Neuropathol. 109, 237-246. doi: 10.1007/s00401-004-0943-y.
36. Dirnagl, U., and Meisel, A. (2008). Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning? Neuropharmacology 55, 334-344. doi: 10.1016/j.neuropharm.2008.02.017.
37. Downes, C. E., and Crack, P. J. (2010). Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br. J. Pharmacol. 160, 1872-1888. doi: 10.1111/j.1476-5381.2010.00864.x.
38. Du, F., Zhu, L., Qian, Z.-M., Wu, X.-M., Yung, W.-H., and Ke, Y. (2010). Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity. Biochim. Biophys. Acta 1802, 1048-1053. doi: 10.1016/j.bbadis.2010.06.013.
39. Duckworth, E. A. M., Butler, T., Collier, L., Collier, S., and Pennypacker, K. R. (2006). NF-κB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 1088, 167-175. doi: 10.1016/j.brainres.2006.02.103.
40. Elliott, M. B., Tuma, R. F., Amenta, P. S., Barbe, M. F., and Jallo, J. I. (2011). Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J. Neurotrauma 28, 973-981. doi: 10.1089/neu.2010.1672.
41. Endres, M., Gertz, K., Lindauer, U., Katchanov, J., Schultze, J., Schröck, H., et al. (2003). Mechanisms of stroke protection by physical activity. Ann. Neurol. 54, 582-590. doi: 10.1002/ana.10722.
42. Foster, S. L., Hargreaves, D. C., and Medzhitov, R. (2007). Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978. doi: 10.1038/nature05836.
43. Gabellec, M. M., Griffais, R., Fillion, G., and Haour, F. (1995). Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment. Brain Res. Mol. Brain Res. 31, 122-130. doi: 10.1016/0169-328X(95)00042-Q.
44. Galea, E., Glickstein, S. B., Feinstein, D. L., Golanov, E. V., and Reis, D. J. (1998a). Stimulation of cerebellar fastigial nucleus inhibits interleukin-1beta-induced cerebrovascular inflammation. Am. J. Physiol. 275, H2053-H2063.
45. Galea, E., Golanov, E. V., Feinstein, D. L., Kobylarz, K. A., Glickstein, S. B., and Reis, D. J. (1998b). Cerebellar stimulation reduces inducible nitric oxide synthase expression and protects brain from ischemia. Am. J. Physiol. 274, H2035-H2045.
46. Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., et al. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61. doi: 10.1111/j.1432-1033.1995.tb20780.x.
47. Gallí, M., Van Gool, F., and Leo, O. (2011). Sirtuins and inflammation: friends or foes? Biochem. Pharmacol. 81, 569-576. doi: 10.1016/j.bcp.2010.12.010.
48. Gesuete, R., Packard, A. E. B., Vartanian, K. B., Conrad, V. K., Stevens, S. L., Bahjat, F. R., et al. (2012). Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling. J. Neurochem. 123(Suppl. 2), 75-85. doi: 10.1111/j.1471-4159.2012.07946.x.
49. Gidday, J. M. (2006). Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 7, 437-448. doi: 10.1038/nrn1927.
50. Ginis, I., Jaiswal, R., Klimanis, D., Liu, J., Greenspon, J., and Hallenbeck, J. M. (2002). TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation: the role of NF-kappaB association with p300 adaptor. J. Cereb. Blood Flow Metab. 22, 142-152. doi: 10.1097/00004647-200202000-00002.
51. Golanov, E. V., Liu, F., and Reis, D. J. (1998). Stimulation of cerebellum protects hippocampal neurons from global ischemia. Neuroreport 9, 819-824. doi: 10.1097/00001756-199803300-00010.
52. Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., et al. (2006). Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071, 10-23. doi: 10.1016/j.brainres.2005.11.035.
53. Guo, M., Lin, V., Davis, W., Huang, T., Carranza, A., Sprague, S., et al. (2008). Preischemic induction of TNF-alpha by physical exercise reduces blood-brain barrier dysfunction in stroke. J. Cereb. Blood Flow Metab. 28, 1422-1430. doi: 10.1038/jcbfm.2008.29.
54. Hallenbeck, J. M. (2002). The many faces of tumor necrosis factor in stroke. Nat. Med. 8, 1363-1368. doi: 10.1038/nm1202-1363.
55. Harari, O. A., and Liao, J. K. (2010). NF-κB and innate immunity in ischemic stroke. Ann. N.Y. Acad. Sci. 1207, 32-40. doi: 10.1111/j.1749-6632.2010.05735.x.
56. Hazzalin, C. A., and Mahadevan, L. C. (2005). Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: analysis at c-fos and c-jun. PLoS Biol. 3:e393. doi: 10.1371/journal.pbio.0030393.
57. Hess, D. C., Hoda, M. N., and Bhatia, K. (2013). Remote limb perconditioning and postconditioning: will it translate into a promising treatment for acute stroke? Stroke 44, 1191-1196. doi: 10.1161/STROKEAHA.112.678482.
58. Hickey, E. J., You, X., Kaimaktchiev, V., Stenzel-Poore, M., and Ungerleider, R. M. (2007). Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 133, 1588-1596. doi: 10.1016/j.jtcvs.2006.12.056.
59. Horiguchi, T., Snipes, J. A., Kis, B., Shimizu, K., and Busija, D. W. (2005). The role of nitric oxide in the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Brain Res. 1039, 84-89. doi: 10.1016/j.brainres.2005.01.047.
60. Horiguchi, T., Snipes, J. A., Kis, B., Shimizu, K., and Busija, D. W. (2006). Cyclooxygenase-2 mediates the development of cortical spreading depression-induced tolerance to transient focal cerebral ischemia in rats. Neuroscience 140, 723-730. doi: 10.1016/j.neuroscience.2006.02.025.
61. Hoshino, K., Sugiyama, T., Matsumoto, M., Tanaka, T., Saito, M., Hemmi, H., et al. (2006). IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 440, 949-953. doi: 10.1038/nature04641.
62. Howlett, A. C. A., Barth, F. F., Bonner, T. I. T., Cabral, G. G., Casellas, P. P., Devane, W. A. W., et al. (2002). International union of pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54, 161-202. doi: 10.1124/pr.54.2.161.
63. Hu, X., Jiang, H., Cui, B., Xu, C., Lu, Z., and He, B. (2010). Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury. Int. J. Cardiol. 145, 111-112. doi: 10.1016/j.ijcard.2009.05.057.
64. Hua, F., Ma, J., Ha, T., Kelley, J., Williams, D. L., Kao, R. L., et al. (2008). Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury. J. Neuroimmunol. 199, 75-82. doi: 10.1016/j.jneuroim.2008.05.009.
65. Huang, J., Upadhyay, U. M., and Tamargo, R. J. (2006). Inflammation in stroke and focal cerebral ischemia. Surg. Neurol. 66, 232-245. doi: 10.1016/j.surneu.2005.12.028.
66. Iadecola, C., and Anrather, J. (2011a). The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808. doi: 10.1038/nm.2399.
67. Iadecola, C., and Anrather, J. (2011b). Stroke research at a crossroad: asking the brain for directions. Nat. Neurosci. 14, 1363-1368. doi: 10.1038/nn.2953.
68. Iadecola, C., Kahles, T., Gallo, E. F., and Anrather, J. (2011). Neurovascular protection by ischaemic tolerance: role of nitric oxide. J. Physiol. (Lond.) 589, 4137-4145. doi: 10.1113/jphysiol.2011.210831.
69. Iadecola, C., Niwa, K., Nogawa, S., Zhao, X., Nagayama, M., Araki, E., et al. (2001). Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 98, 1294-1299. doi: 10.1073/pnas.98.3.1294.
70. Ikeda, T., Xia, X. Y., Xia, Y. X., and Ikenoue, T. (1999). Hyperthermic preconditioning prevents blood-brain barrier disruption produced by hypoxia-ischemia in newborn rat. Brain Res. Dev. Brain Res. 117, 53-58. doi: 10.1016/S0165-3806(99)00097-8.
71. Izuishi, K., Tsung, A., Jeyabalan, G., Critchlow, N. D., Li, J., Tracey, K. J., et al. (2006). Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J. Immunol. 176, 7154-7158.
72. Jaerve, A., and Müller, H. W. (2012). Chemokines in CNS injury and repair. Cell Tissue Res. 349, 229-248. doi: 10.1007/s00441-012-1427-3.
73. Jander, S., Schroeter, M., Peters, O., Witte, O. W., and Stoll, G. (2001). Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J. Cereb. Blood Flow Metab. 21, 218-225. doi: 10.1097/00004647-200103000-00005.
74. Jung, F., Palmer, L. A., Zhou, N., and Johns, R. A. (2000). Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86, 319-325. doi: 10.1161/01.RES.86.3.319.
75. Kahles, T., Luedike, P., Endres, M., Galla, H.-J., Steinmetz, H., Busse, R., et al. (2007). NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38, 3000-3006. doi: 10.1161/STROKEAHA.107.489765.
76. Kaltschmidt, B., Widera, D., and Kaltschmidt, C. (2005). Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 1745, 287-299. doi: 10.1016/j.bbamcr.2005.05.009.
77. Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., and Baeuerle, P. A. (1994). Constitutive NF-kappa B activity in neurons. Mol. Cell Biol. 14, 3981-3992.
78. Kapinya, K. J., Löwl, D., Fütterer, C., Maurer, M., Waschke, K. F., Isaev, N. K., et al. (2002). Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33, 1889-1898. doi: 10.1161/01.STR.0000020092.41820.58.
79. Kawahara, N., Ruetzler, C. A., and Klatzo, I. (1995). Protective effect of spreading depression against neuronal damage following cardiac arrest cerebral ischaemia. Neurol. Res. 17, 9-16.
80. Kawahara, N., Ruetzler, C. A., Mies, G., and Klatzo, I. (1999). Cortical spreading depression increases protein synthesis and upregulates basic fibroblast growth factor. Exp. Neurol. 158, 27-36. doi: 10.1006/exnr.1999.7091.
81. Kawai, N. N., Okauchi, M. M., Morisaki, K. K., and Nagao, S. S. (2000). Effects of delayed intraischemic and postischemic hypothermia on a focal model of transient cerebral ischemia in rats. Stroke 31, 1982-1989. doi: 10.1161/01.STR.31.8.1982.
82. Kawano, T., Kunz, A., Abe, T., Girouard, H., Anrather, J., Zhou, P., et al. (2007). iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite. J. Cereb. Blood Flow Metab. 27, 1453-1462. doi: 10.1038/sj.jcbfm.9600449.
83. Keep, R. F., Wang, M. M., Xiang, J., Hua, Y., and Xi, G. (2010). Is there a place for cerebral preconditioning in the clinic? Transl. Stroke Res. 1, 4-18. doi: 10.1007/s12975-009-0007-7.
84. Kim, J. B. (2006). HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26, 6413-6421. doi: 10.1523/JNEUROSCI.3815-05.2006.
85. Kirino, T. (2002). Ischemic tolerance. J. Cereb. Blood Flow Metab. 22, 1283-1296. doi: 10.1097/00004647-200211000-00001.
86. Kitagawa, K., Matsumoto, M., Tagaya, M., Hata, R., Ueda, H., Niinobe, M., et al. (1990). "Ischemic tolerance" phenomenon found in the brain. Brain Res. 528, 21-24. doi: 10.1016/0006-8993(90)90189-I.
87. Konstantinov, I. E., Arab, S., Kharbanda, R. K., Li, J., Cheung, M. M. H., Cherepanov, V., et al. (2004). The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol. Genomics 19, 143-150. doi: 10.1152/physiolgenomics.00046.2004.
88. Kunkler, P. E., Hulse, R. E., and Kraig, R. P. (2004). Multiplexed cytokine protein expression profiles from spreading depression in hippocampal organotypic cultures. J. Cereb. Blood Flow Metab. 24, 829-839. doi: 10.1097/01.WCB.0000126566.34753.30.
89. Kunz, A., Anrather, J., Zhou, P., Orio, M., and Iadecola, C. (2006). Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J. Cereb. Blood Flow Metab. 27, 545-551. doi: 10.1038/sj.jcbfm.9600369.
90. Kunz, A., Park, L., Abe, T., Gallo, E. F., Anrather, J., Zhou, P., et al. (2007). Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species. J. Neurosci. 27, 7083-7093. doi: 10.1523/JNEUROSCI.1645-07.2007.
91. Lee, S.-T., Chu, K., Jung, K.-H., Yoon, H.-J., Jeon, D., Kang, K.-M., et al. (2010). MicroRNAs induced during ischemic preconditioning. Stroke 41, 1646-1651. doi: 10.1161/STROKEAHA.110.579649.
92. Leker, R. R., Gai, N., Mechoulam, R., and Ovadia, H. (2003). Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke 34, 2000-2006. doi: 10.1161/01.STR.0000079817.68944.1E.
93. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., and Hoffmann, J. A. (1996). The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983. doi: 10.1016/S0092-8674(00)80172-5.
94. Leung, A. K. L., and Sharp, P. A. (2010). MicroRNA functions in stress responses. Mol. Cell 40, 205-215. doi: 10.1016/j.molcel.2010.09.027.
95. Leung, P. Y., Packard, A. E., and Stenzel-Poore, M. P. (2009). It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection. Future Neurol. 4, 201-208. doi: 10.2217/14796708.4.2.201.
96. Leung, P. Y., Stevens, S. L., Packard, A. E. B., Lessov, N. S., Yang, T., Conrad, V. K., et al. (2012). Toll-like receptor 7 preconditioning induces robust neuroprotection against stroke by a novel type I interferon-mediated mechanism. Stroke 43, 1383-1389. doi: 10.1161/STROKEAHA.111.641522.
97. Li, Q., and Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734. doi: 10.1038/nri910.
98. Li, Q.-F., Zhu, Y.-S., Jiang, H., Xu, H., and Sun, Y. (2009). Heme oxygenase-1 mediates the anti-inflammatory effect of isoflurane preconditioning in LPS-stimulated macrophages. Acta Pharmacol. Sin. 30, 228-234. doi: 10.1038/aps.2008.19.
99. Liang, J., Wang, J., Saad, Y., Warble, L., Becerra, E., and Kolattukudy, P. E. (2011). Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines. J. Neuroinflammation 8:182. doi: 10.1186/1742-2094-8-182.
100. Liu, C., Peng, Z., Zhang, N., Yu, L., Han, S., Li, D., et al. (2012). Identification of differentially expressed microRNAs and their PKC-isoform specific gene network prediction during hypoxic pre-conditioning and focal cerebral ischemia of mice. J. Neurochem. 120, 830-841. doi: 10.1111/j.1471-4159.2011.07624.x.
101. Liu, J., Ginis, I., Spatz, M., and Hallenbeck, J. M. (2000). Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am. J. Physiol. Cell Physiol. 278, C144-C153.
102. Loddick, S. A., Turnbull, A. V., and Rothwell, N. J. (1998). Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18, 176-179. doi: 10.1097/00004647-199802000-00008.
103. Lu, C., Liu, L., Chen, Y., Ha, T., Kelley, J., Schweitzer, J., et al. (2011). TLR2 ligand induces protection against cerebral ischemia/reperfusion injury via activation of phosphoinositide 3-kinase/Akt signaling. J. Immunol. 187, 1458-1466. doi: 10.4049/jimmunol.1003428.
104. Lusardi, T. A., Farr, C. D., Faulkner, C. L., Pignataro, G., Yang, T., Lan, J., et al. (2010). Ischemic preconditioning regulates expression of microRNAs and a predicted target, MeCP2, in mouse cortex. J. Cereb. Blood Flow Metab. 30, 744-756. doi: 10.1038/jcbfm.2009.253.
105. Ma, L., Zhu, Z., Zhao, Y., Hou, L., Wang, Q., Xiong, L., et al. (2011). Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia. Curr. Neurovasc. Res. 8, 145-152. doi: 10.2174/156720211795495394.
106. Macrez, R., Ali, C., Toutirais, O., Le Mauff, B., Defer, G., Dirnagl, U., et al. (2011). Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 10, 471-480. doi: 10.1016/S1474-4422(11)70066-7.
107. Mallard, C. (2012). Innate immune regulation by toll-like receptors in the brain. ISRN Neurol. 2012:701950. doi: 10.5402/2012/701950.
108. Marsh, B., Stevens, S. L., Packard, A. E. B., Gopalan, B., Hunter, B., Leung, P. Y., et al. (2009b). Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J. Neurosci. 29, 9839-9849. doi: 10.1523/JNEUROSCI.2496-09.2009.
109. Marsh, B. J., Williams-Karnesky, R. L., and Stenzel-Poore, M. P. (2009a). Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience 158, 1007-1020. doi: 10.1016/j.neuroscience.2008.07.067.
110. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564. doi: 10.1038/346561a0.
111. McColl, B. W., Allan, S. M., and Rothwell, N. J. (2009). Systemic infection, inflammation and acute ischemic stroke. Neuroscience 158, 1049-1061. doi: 10.1016/j.neuroscience.2008.08.019.
112. Meisel, C., Schwab, J. M., Prass, K., Meisel, A., and Dirnagl, U. (2005). Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6, 775-786. doi: 10.1038/nrn1765.
113. Mercer, T. R., Dinger, M. E., and Mattick, J. S. (2009). Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10, 155-159. doi: 10.1038/nrg2521.
114. Morris, K. C., Lin, H. W., Thompson, J. W., and Perez-Pinzon, M. A. (2011). Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J. Cereb. Blood Flow Metab. 31, 1003-1019. doi: 10.1038/jcbfm.2010.229.
115. Nagayama, T. T., Sinor, A. D. A., Simon, R. P. R., Chen, J. J., Graham, S. H. S., Jin, K. K., et al. (1999). Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neurosci. 19, 2987-2995.
116. Narayanan, S. V., Dave, K. R., and Perez-Pinzon, M. A. (2013). Ischemic preconditioning and clinical scenarios. Curr. Opin. Neurol. 26, 1-7. doi: 10.1097/WCO.0b013e32835bf200.
117. Nathan, C. (1997). Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100, 2417-2423. doi: 10.1172/JCI119782.
118. Nawashiro, H., Tasaki, K., Ruetzler, C. A., and Hallenbeck, J. M. (1997). TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17, 483-490. doi: 10.1097/00004647-199705000-00001.
119. Nijboer, C. H., Heijnen, C. J., Groenendaal, F., May, M. J., van Bel, F., and Kavelaars, A. (2008). A dual role of the NF-kappaB pathway in neonatal hypoxic-ischemic brain damage. Stroke 39, 2578-2586. doi: 10.1161/STROKEAHA.108.516401.
120. Nishio, S., Yunoki, M., Chen, Z. F., Anzivino, M. J., and Lee, K. S. (2000). Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J. Neurosurg. 93, 845-851. doi: 10.3171/jns.2000.93.5.0845.
121. Nurmi, A. (2004). Nuclear factor-B contributes to infarction after permanent focal ischemia. Stroke 35, 987-991. doi: 10.1161/01.STR.0000120732.45951.26.
122. Nurmi, A., Vartiainen, N., Pihlaja, R., Goldsteins, G., Yrjanheikki, J., and Koistinaho, J. (2004). Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J. Neurochem. 91, 755-765. doi: 10.1111/j.1471-4159.2004.02756.x.
123. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., and Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U.S.A. 106, 7113-7118. doi: 10.1073/pnas.0902636106.
124. O'Connell, R. M., Rao, D. S., and Baltimore, D. (2012). microRNA regulation of inflammatory responses. Annu. Rev. Immunol. 30, 295-312. doi: 10.1146/annurev-immunol-020711-075013.
125. Ohtsuki, T., Ruetzler, C. A., Tasaki, K., and Hallenbeck, J. M. (1996). Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J. Cereb. Blood Flow Metab. 16, 1137-1142. doi: 10.1097/00004647-199611000-00007.
126. O'Neill, L. A., Sheedy, F. J., and McCoy, C. E. (2011). MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nat. Rev. Immunol. 11, 163-175. doi: 10.1038/nri2957.
127. Ota, A., Ikeda, T., Xia, X. Y., Xia, Y. X., and Ikenoue, T. (2000). Hypoxic-ischemic tolerance induced by hyperthermic pretreatment in newborn rats. J. Soc. Gynecol. Investig. 7, 102-105. doi: 10.1016/S1071-5576(00)00038-1.
128. Pacher, P., Bátkai, S., and Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389-462. doi: 10.1124/pr.58.3.2.
129. Pacher, P., and Haskó, G. (2008). Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 153, 252-262. doi: 10.1038/sj.bjp.0707582.
130. Packard, A. E. B., Hedges, J. C., Bahjat, F. R., Stevens, S. L., Conlin, M. J., Salazar, A. M., et al. (2012). Poly-IC preconditioning protects against cerebral and renal ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 32, 242-247. doi: 10.1038/jcbfm.2011.160.
131. Pahl, H. L. (1999). Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866. doi: 10.1038/sj.onc.1203239.
132. Panikashvili, D., Mechoulam, R., Beni, S. M., Alexandrovich, A., and Shohami, E. (2005). CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition. J. Cereb. Blood Flow Metab. 25, 477-484. doi: 10.1038/sj.jcbfm.9600047.
133. Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanus, L., Breuer, A., Mechoulam, R., et al. (2001). An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413, 527-531. doi: 10.1038/35097089.
134. Park, M. K., Kang, Y. J., Lee, H. S., Kim, H. J., Seo, H. G., Lee, J. H., et al. (2008). The obligatory role of COX-2 expression for induction of HO-1 in ischemic preconditioned rat brain. Biochem. Biophys. Res. Commun. 377, 1191-1194. doi: 10.1016/j.bbrc.2008.10.149.
135. Patel, H., Shaw, S. G., Shi-Wen, X., Abraham, D., Baker, D. M., and Tsui, J. C. S. (2012). Toll-like receptors in ischaemia and its potential role in the pathophysiology of muscle damage in critical limb ischaemia. Cardiol. Res. Pract. 2012:121237. doi: 10.1155/2012/121237.
136. Pedersen, B. K. (2011). Exercise-induced myokines and their role in chronic diseases. Brain Behav. Immun. 25, 811-816. doi: 10.1016/j.bbi.2011.02.010.
137. Pedersen, C. M., Cruden, N. L., Schmidt, M. R., Lau, C., Bøtker, H. E., Kharbanda, R. K., et al. (2011). Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans. J. Thromb. Haemost. 9, 404-407. doi: 10.1111/j.1538-7836.2010.04142.x.
138. Peng, Z., Ren, P., Kang, Z., Du, J., Lian, Q., Liu, Y., et al. (2008). Up-regulated HIF-1a is involved in the hypoxic tolerance induced by hyperbaric oxygen preconditioning. Brain Res. 1212, 71-78. doi: 10.1016/j.brainres.2008.03.027.
139. Plamondon, H., Blondeau, N., Heurteaux, C., and Lazdunski, M. (1999). Mutually protective actions of kainic acid epileptic preconditioning and sublethal global ischemia on hippocampal neuronal death: involvement of adenosine A1 receptors and K(ATP) channels. J. Cereb. Blood Flow Metab. 19, 1296-1308. doi: 10.1097/00004647-199912000-00002.
140. Pradillo, J. M., Fernández-López, D., García-Yébenes, I., Sobrado, M., Hurtado, O., Moro, M. A., et al. (2009). Toll-like receptor 4 is involved in neuroprotection afforded by ischemic preconditioning. J. Neurochem. 109, 287-294. doi: 10.1111/j.1471-4159.2009.05972.x.
141. Pradillo, J. M., Romera, C., Hurtado, O., Cárdenas, A., Moro, M. A., Leza, J. C., et al. (2005). TNFR1 upregulation mediates tolerance after brain ischemic preconditioning. J. Cereb. Blood Flow Metab. 25, 193-203. doi: 10.1038/sj.jcbfm.9600019.
142. Pun, P. B. L., Lu, J., and Moochhala, S. (2009). Involvement of ROS in BBB dysfunction. Free Radic. Res. 43, 348-364. doi: 10.1080/10715760902751902.
143. Quintin, J., Saeed, S., Martens, J. H. A., Giamarellos-Bourboulis, E. J., Ifrim, D. C., Logie, C., et al. (2012). Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223-232. doi: 10.1016/j.chom.2012.06.006.
144. Qureshi, I. A., and Mehler, M. F. (2010). Emerging role of epigenetics in stroke: part 1: DNA methylation and chromatin modifications. Arch. Neurol. 67, 1316-1322. doi: 10.1001/archneurol.2010.275.
145. Ramirez-Carrozzi, V. R., Nazarian, A. A., Li, C. C., Gore, S. L., Sridharan, R., Imbalzano, A. N., et al. (2006). Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response. Genes Dev. 20, 282-296. doi: 10.1101/gad.1383206.
146. Ransohoff, R. M., and Brown, M. A. (2012). Innate immunity in the central nervous system. J. Clin.l Invest. 122, 1164-1171. doi: 10.1172/JCI58644.
147. Rehni, A. K., and Singh, T. G. (2012). Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice. Cytokine 60, 83-89. doi: 10.1016/j.cyto.2012.05.009.
148. Reis, D. J., Berger, S. B., Underwood, M. D., and Khayata, M. (1991). Electrical stimulation of cerebellar fastigial nucleus reduces ischemic infarction elicited by middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 11, 810-818. doi: 10.1038/jcbfm.1991.139.
149. Reis, D. J., Kobylarz, K., Yamamoto, S., and Golanov, E. V. (1998). Brief electrical stimulation of cerebellar fastigial nucleus conditions long-lasting salvage from focal cerebral ischemia: conditioned central neurogenic neuroprotection. Brain Res. 780, 161-165. doi: 10.1016/S0006-8993(97)01017-2.
150. Rosenzweig, H. L., Lessov, N. S., Henshall, D. C., Minami, M., Simon, R. P., and Stenzel-Poore, M. P. (2004). Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice. Stroke 35, 2576-2581. doi: 10.1161/01.STR.0000143450.04438.ae.
151. Rosenzweig, H. L., Minami, M., Lessov, N. S., Coste, S. C., Stevens, S. L., Henshall, D. C., et al. (2007). Endotoxin preconditioning protects against the cytotoxic effects of TNFalpha after stroke: a novel role for TNFalpha in LPS-ischemic tolerance. J. Cereb. Blood Flow Metab. 27, 1663-1674. doi: 10.1038/sj.jcbfm.9600464.
152. Rüegger, S., and Großhans, H. (2012). MicroRNA turnover: when, how, and why. Trends Biochem. Sci. 37, 436-446. doi: 10.1016/j.tibs.2012.07.002.
153. Schwaninger, M., Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., and Wirth, T. (1999). NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5, 554-559. doi: 10.1038/8432.
154. Semple, B. D., Kossmann, T., and Morganti-Kossmann, M. C. (2009). Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 30, 459-473. doi: 10.1038/jcbfm.2009.240.
155. Shichita, T., Hasegawa, E., Kimura, A., Morita, R., Sakaguchi, R., Takada, I., et al. (2012). Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med. 18, 911-917. doi: 10.1038/nm.2749.
156. Shimizu, M., Saxena, P., Konstantinov, I. E., Cherepanov, V., Cheung, M. M. H., Wearden, P., et al. (2010). Remote ischemic preconditioning decreases adhesion and selectively modifies functional responses of human neutrophils. J. Surg. Res. 158, 155-161. doi: 10.1016/j.jss.2008.08.010.
157. Shin, J. A., Park, E.-M., Choi, J.-S., Seo, S.-M., Kang, J. L., Lee, K.-E., et al. (2009). Ischemic preconditioning-induced neuroprotection is associated with differential expression of IL-1beta and IL-1 receptor antagonist in the ischemic cortex. J. Neuroimmunol. 217, 14-19. doi: 10.1016/j.jneuroim.2009.06.001.
158. Shpargel, K. B., Jalabi, W., Jin, Y., Dadabayev, A., Penn, M. S., and Trapp, B. D. (2008). Preconditioning paradigms and pathways in the brain. Cleve. Clin. J. Med. 75(Suppl. 2), S77-S82. doi: 10.3949/ccjm.75.Suppl_2.S77.
159. Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., and Krystal, G. (2004). LPS-Induced Upregulation of SHIP is essential for endotoxin tolerance. Immunity 21, 227-239. doi: 10.1016/j.immuni.2004.07.010.
160. Stapels, M., Piper, C., Yang, T., Li, M., Stowell, C., Xiong, Z. G., et al. (2010). Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance. Sci. Signal. 3, ra15-ra15. doi: 10.1126/scisignal.2000502.
161. Stenzel-Poore, M. P., Stevens, S. L., Xiong, Z., Lessov, N. S., Harrington, C. A., Mori, M., et al. (2003). Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362, 1028-1037. doi: 10.1016/S0140-6736(03)14412-1.
162. Stephenson, D., Yin, T., Smalstig, E. B., Hsu, M. A., Panetta, J., Little, S., et al. (2000). Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20, 592-603. doi: 10.1097/00004647-200003000-00017.
163. Stevens, S. L., Ciesielski, T. M. P., Marsh, B. J., Yang, T., Homen, D. S., Boule, J.-L., et al. (2008). Toll-like receptor 9: a new target of ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 28, 1040-1047. doi: 10.1038/sj.jcbfm.9600606.
164. Stevens, S. L., Leung, P. Y., Vartanian, K. B., Gopalan, B., Yang, T., Simon, R. P., et al. (2011). Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J. Neurosci. 31, 8456-8463. doi: 10.1523/JNEUROSCI.0821-11.2011.
165. Stowe, A. M., Wacker, B. K., Cravens, P. D., Perfater, J. L., Li, M. K., Hu, R., et al. (2012). CCL2 upregulation triggers hypoxic preconditioning-induced protection from stroke. J. Neuroinflammation 9:33. doi: 10.1186/1742-2094-9-33.
166. Stridh, L., Smith, P. L. P., Naylor, A. S., Wang, X., and Mallard, C. (2011). Regulation of toll-like receptor 1 and-2 in neonatal mice brains after hypoxia-ischemia. J. Neuroinflammation 8:45. doi: 10.1186/1742-2094-8-45.
167. Suzuki, H. I., Arase, M., Matsuyama, H., Choi, Y. L., Ueno, T., Mano, H., et al. (2011). MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 44, 424-436. doi: 10.1016/j.molcel.2011.09.012.
168. Swigut, T., and Wysocka, J. (2007). H3K27 demethylases, at long last. Cell 131, 29-32. doi: 10.1016/j.cell.2007.09.026.
169. Tapuria, N., Kumar, Y., Habib, M. M., Abu-Amara, M., Seifalian, A. M., and Davidson, B. R. (2008). Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury-a review. J. Surg. Res. 150, 304-330. doi: 10.1016/j.jss.2007.12.747.
170. Tasaki, K., Ruetzler, C. A., Ohtsuki, T., Martin, D., Nawashiro, H., and Hallenbeck, J. M. (1997). Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267-270. doi: 10.1016/S0006-8993(96)01383-2.
171. Towfighi, J., Housman, C., Mauger, D., and Vannucci, R. C. (1999). Effect of seizures on cerebral hypoxic-ischemic lesions in immature rats. Brain Res. Dev. Brain Res. 113, 83-95. doi: 10.1016/S0165-3806(99)00004-8.
172. Trinchieri, G. (2010). Type I interferon: friend or foe? J. Exp. Med. 207, 2053-2063. doi: 10.1084/jem.20101664.
173. Ullrich, O., Merker, K., Timm, J., and Tauber, S. (2007). Immune control by endocannabinoids-new mechanisms of neuroprotection? J. Neuroimmunol. 184, 127-135. doi: 10.1016/j.jneuroim.2006.11.018.
174. Vabulas, R. M., Ahmad-Nejad, P., Ghose, S., Kirschning, C. J., Issels, R. D., and Wagner, H. (2002). HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277, 15107-15112. doi: 10.1074/jbc.M111204200.
175. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., and Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596.
176. van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., and Olson, E. N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579. doi: 10.1126/science.1139089.
177. Vartanian, K., and Stenzel-Poore, M. (2010). Toll-like receptor tolerance as a mechanism for neuroprotection. Transl. Stroke Res. 1, 252-260. doi: 10.1007/s12975-010-0033-5.
178. Vartanian, K. B., Stevens, S. L., Marsh, B. J., Williams-Karnesky, R., Lessov, N. S., and Stenzel-Poore, M. P. (2011). LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury. J. Neuroinflammation 8:140. doi: 10.1186/1742-2094-8-140.
179. Veldhuis, W. B., Derksen, J. W., Floris, S., van der Meide, P. H., de Vries, H. E., Schepers, J., et al. (2003). Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J. Cereb. Blood Flow Metab. 1029-1039. doi: 10.1097/01.WCB.0000080703.47016.B6.
180. Verstak, B., Hertzog, P., and Mansell, A. (2007). Toll-like receptor signalling and the clinical benefits that lie within. Inflamm. Res. 56, 1-10. doi: 10.1007/s00011-007-6093-7.
181. Verstrepen, L., Verhelst, K., van Loo, G., Carpentier, I., Ley, S. C., and Beyaert, R. (2010). Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem. Pharmacol. 80, 2009-2020. doi: 10.1016/j.bcp.2010.06.044.
182. Vezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., et al. (2002). Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 43(Suppl. 5), 30-35. doi: 10.1046/j.1528-1157.43.s.5.14.x.
183. Vlasov, T. D., Korzhevskii, D. E., and Polyakova, E. A. (2005). Ischemic preconditioning of the rat brain as a method of endothelial protection from ischemic/repercussion injury. Neurosci. Behav. Physiol. 35, 567-572. doi: 10.1007/s11055-005-0095-0.
184. Wacker, B. K., Perfater, J. L., and Gidday, J. M. (2012). Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway. J. Neurochem. 123, 954-962. doi: 10.1111/jnc.12047.
185. Wang, F., Birch, S. E., He, R., Tawadros, P., Szaszi, K., Kapus, A., et al. (2010). Remote ischemic preconditioning by hindlimb occlusion prevents liver ischemic/reperfusion injury. Ann. Surg. 251, 292-299. doi: 10.1097/SLA.0b013e3181bfda8c.
186. Wang, L., Traystman, R. J., and Murphy, S. J. (2008). Inhalational anesthetics as preconditioning agents in ischemic brain. Curr. Opin. Pharmacol. 8, 104-110. doi: 10.1016/j.coph.2007.09.005.
187. Wang, Q., Peng, Y., Chen, S., Gou, X., Hu, B., Du, J., et al. (2009). Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 40, 2157-2164. doi: 10.1161/STROKEAHA.108.541490.
188. Wang, Q., Xiong, L., Chen, S., Liu, Y., and Zhu, X. (2005). Rapid tolerance to focal cerebral ischemia in rats is induced by preconditioning with electroacupuncture: window of protection and the role of adenosine. Neurosci. Lett. 381, 158-162. doi: 10.1016/j.neulet.2005.02.019.
189. Wang, R. Y., Yang, Y. R., and Yu, S. M. (2001). Protective effects of treadmill training on infarction in rats. Brain Res. 922, 140-143. doi: 10.1016/S0006-8993(01)03154-7.
190. Wang, X., Li, X., Currie, R. W., Willette, R. N., Barone, F. C., and Feuerstein, G. Z. (2000). Application of real-time polymerase chain reaction to quantitate induced expression of interleukin-1beta mRNA in ischemic brain tolerance. J. Neurosci. Res. 59, 238-246. doi: 10.1016/S1385-299X(00)00015-5.
191. Wang, Y., Wang, Y., and Yang, G.-Y. (2013). MicroRNAs in cerebral ischemia. Stroke Res. Treat. 2013:276540. doi: 10.1155/2013/276540.
192. Wang, Y.-C., Lin, S., and Yang, Q.-W. (2011). Toll-like receptors in cerebral ischemic inflammatory injury. J. Neuroinflammation 8:134. doi: 10.1186/1742-2094-8-134.
193. Wu, T.-C., and Grotta, J. C. (2013). Hypothermia for acute ischaemic stroke. Lancet Neurol. 12, 275-284. doi: 10.1016/S1474-4422(13)70013-9.
194. Yanamoto, H., Hashimoto, N., Nagata, I., and Kikuchi, H. (1998). Infarct tolerance against temporary focal ischemia following spreading depression in rat brain. Brain Res. 784, 239-249. doi: 10.1016/S0006-8993(97)01344-9.
195. Yang, Q.-W., Lu, F.-L., Zhou, Y., Wang, L., Zhong, Q., Lin, S., et al. (2011). HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J. Cereb. Blood Flow Metab. 31, 593-605. doi: 10.1038/jcbfm.2010.129.
196. Yin, W., Signore, A. P., Iwai, M., Cao, G., Gao, Y., Johnnides, M. J., et al. (2007). Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 38, 1017-1024. doi: 10.1161/01.STR.0000258102.18836.ca.
197. Yoshimura, A., Naka, T., and Kubo, M. (2007). SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465. doi: 10.1038/nri2093.
198. Yu, J. T., Lee, C. H., Yoo, K.-Y., Choi, J. H., Li, H., Park, O. K., et al. (2010). Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J. Neurol. Sci. 296, 69-78. doi: 10.1016/j.jns.2010.06.004.
199. Yunoki, M., Nishio, S., Ukita, N., Anzivino, M. J., and Lee, K. S. (2003). Hypothermic preconditioning induces rapid tolerance to focal ischemic injury in the rat. Exp. Neurol. 181, 291-300. doi: 10.1016/S0014-4886(03)00056-6.
200. Zhang, F., Wu, Y., and Jia, J. (2011). Exercise preconditioning and brain ischemic tolerance. Neuroscience 177, 170-176. doi: 10.1016/j.neuroscience.2011.01.018.
201. Zhang, M., Adler, M. W., Abood, M. E., Ganea, D., Jallo, J., and Tuma, R. F. (2009). CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury. Microvasc. Res. 78, 86-94. doi: 10.1016/j.mvr.2009.03.005.
202. Zhang, M., Martin, B. R., Adler, M. W., Razdan, R. K., Jallo, J. I., and Tuma, R. F. (2007). Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model. J. Cereb. Blood Flow Metab. 27, 1387-1396. doi: 10.1038/sj.jcbfm.9600447.
203. Zhao, P., and Zuo, Z. (2004). Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 101, 695-703. doi: 10.1097/00000542-200409000-00018.
204. Zhou, P., Qian, L., D'Aurelio, M., Cho, S., Wang, G., Manfredi, G., et al. (2012). Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. J. Neurosci. 32, 583-592. doi: 10.1523/JNEUROSCI.2849-11.2012.
205. Zhou, P., Qian, L., Zhou, T., and Iadecola, C. (2005). Mitochondria are involved in the neurogenic neuroprotection conferred by stimulation of cerebellar fastigial nucleus. J. Neurochem. 95, 221-229. doi: 10.1111/j.1471-4159.2005.03358.x.
206. Zhuang, S.-Y., Bridges, D., Grigorenko, E., McCloud, S., Boon, A., Hampson, R. E., et al. (2005). Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. Neuropharmacology 48, 1086-1096. doi: 10.1016/j.neuropharm.2005.01.005.
207. Zimmermann, C., Ginis, I., Furuya, K., Klimanis, D., Ruetzler, C., Spatz, M., et al. (2001). Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res. 895, 59-65. doi: 10.1016/S0006-8993(01)02028-5.
208. Zwagerman, N., Plumlee, C., Guthikonda, M., and Ding, Y. (2010). Toll-like receptor-4 and cytokine cascade in stroke after exercise. Neurol. Res. 32, 123-126. doi: 10.1179/016164109X12464612122812.